Continuous Price Reduction Expected to Shrink Pharmaceutical Industry

Published: 2001-10-10 06:59:00

Updated: 2001-10-10 06:59:00

The Korea Pharmaceutical Manufacturers Association (KPMA) has announced that the continuing medicine price reductions initiated by the government is not only hindering the growth of the pharmaceutical industry which would rise to a core industry in the bioengineering era, but also played an insig...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK